Mylan picks 3M to manufacture its generic Advair inhaler for U.K. market

Mylan ($MYL) said on Monday that it had started selling in the U.K. its generic of GlaxoSmithKline's ($GSK) asthma treatment Seretide Evohaler, known better in the U.S. as Advair. Mylan said the inhalers will be assembled and packaged for it by 3M Drug Delivery Systems at the 3M ($MMM) manufacturing facility in Loughborough, U.K. There are already other generics in the U.K. of the blockbuster, which in 2013 turned in sales of $8.6 billion. The growing competition has taken a big bite out of GSK's revenues, leading it to make layoffs in the U.S. Release | More